Click Title for complete article or
click Summary for overview of each
article.
Gene
Network Sciences Announces Cancer Collaboration
with University of Connecticut Health Center's
Neag Comprehensive Cancer
Center
From
PR Newswire US - Jun 03,
2009
Gene Network
Sciences, Inc. today announced that it has entered
into a research collaboration with The University
of Connecticut Health Center's Carole and Ray Neag
Comprehensive Cancer Center in which the parties
will incorporate genetic, genomic and clinical
data together into computer models of different
cancers to be used to identify the best treatments
for individual patients and to
develo...
[ Summary
]
Inovio
Biomedical Influenza DNA Vaccines Demonstrate
Potential to Protect Against Newly Emerging Flu
Strains with Pandemic
Potential
From PharmaLive News Archive -
Jun 01,
2009
SAN
DIEGO--(BUSINESS WIRE)--Jun 2, 2009 - Inovio
Biomedical Corporation, a leader in DNA vaccine
discovery, development and delivery, announced
today preclinical data from two studies of
influenza DNA vaccines designed using its SynCon
technology.
[ Summary
]
| Genetics & Genomics
Research |
| Click Title for complete article or
click Summary for overview of each
article.
Roche
NimbleGen Introduces the MS 200 Microarray
Scanner, Unleashing the Full Potential of
NimbleGen Arrays
From PharmaLive News Archive -
Jun 02,
2009
MADISON,
Wis.--(BUSINESS WIRE)--Jun 3, 2009 - Roche
NimbleGen introduces a new high-resolution
scanning instrument, the NimbleGen MS 200
Microarray Scanner. The MS 200 is the first
scanner optimized to reveal the full potential and
capture the complete picture from all NimbleGen
DNA microarrays.
[
Summary
]
Microsoft
buying Rosetta's genomic-software assets from
Merck [Seattle Times]
From Seattle Times (WA) -
Jun 02,
2009
Jun.
2--Microsoft is buying assets of Seattle-based
Rosetta Biosoftware from pharmaceutical giant
Merck. Microsoft wants to incorporate Rosetta's
genomic-information software into the Microsoft
Amalga Life Sciences platform, a system the
company's Health Solutions Group has built for
research institutions such as drug companies and
universities.
[ Summary
]
Genzyme
Completes Transaction with Bayer
HealthCare
From PharmaLive News Archive -
Jun 01,
2009
CAMBRIDGE,
Mass.--(BUSINESS WIRE)--Jun 2, 2009 - Genzyme
Corp. announced today that it has completed the
transaction with Bayer HealthCare to acquire the
worldwide rights to Campath/MabCampath
(alemtuzumab), giving Genzyme primary
responsibility for the development and
commercialization of this promising multiple
sclerosis (MS) therapeutic candidate.
[ Summary
]
Affymetrix
Chief Medical Officer to speak at AAAS on
Personalized Medicine
From PharmaLive News Archive -
May 28,
2009
SANTA CLARA,
Calif.--(BUSINESS WIRE)--May 29, 2009 -
Affymetrix, Inc., today announced that its Chief
Medical Officer, Dr. Rick Hockett, will address
the topic of ?Personalized Medicine: Planning for
the Future' at a meeting of the American
Association for the Advancement of Science (AAAS)
and the Food and Drug Law Institute (FDLI) on June
1 in Washington, DC.
[ Summary
]
Healthcare
Companies See Opportunity in Personalized
Medicine
From Market Wire - Jun 01, 2009
06/01/09 -- MarketResearch.com has
announced the addition of Kalorama Information's
new report "Pharmacodiagnostics and Personalized
Medicine 2009," to their collection of Healthcare
market reports.
[
Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Cephalon
introduces new prescription sleep
drug
From
Datamonitor - Jun 03,
2009
Cephalon, a
biopharmaceutical company, has reported that
Nuvigil tablets, a longer-lasting formulation of
modafinil, is now available in the
US.
[ Summary
]
One-Year
Phase III Study Confirms Ilaris(R) Offers
Long-Term Remission in Patients With CAPS, a
Severe Lifelong Auto-Inflammatory
Disease
From
PR Newswire Europe & UK Disclose -
Jun 03,
2009
- Not for US
Media. - New Ilaris Data in The New England
Journal of Medicine Show Rapid Sustained Efficacy
in Patients With Cryopyrin-Associated Periodic
Syndrome.
[ Summary
]
GSK
may seek links with startups [The News &
Observer, Raleigh, N.C.]
From News & Observer
(Raleigh, NC) - Jun 03,
2009
Jun.
3--RALEIGH -- GlaxoSmithKline is considering
setting up new facilities at its main research
sites worldwide, including in Research Triangle
Park, where it could help small biotechnology
companies develop medicines.
[ Summary
]
Epistem
Presents Further Data Supporting its Plucked Hair
Biomarker technology at the Institute of Cancer
Research Centenary Conference
From PharmaLive News Archive -
Jun 02,
2009
MANCHESTER,
England, June 3, 2009- Epistem plc, the UK
biotechnology and contract research company, will
present preclinical results from its recently
completed plucked hair biomarker study at the
Institute of Cancer Research Centenary Conference,
in Queen Elizabeth II Conference Centre, London,
UK on 8th to 10th June 2009.
[ Summary
]
New
One-Year Data from REMICADE(R) SONIC Trial Show
Sustained Efficacy Compared with Azathioprine in
Treatment of Crohn's Disease
From PR Newswire US -
Jun 02,
2009
First-of-its-Kind Study
Demonstrates REMICADE More Likely to Maintain
Steroid-Free Remission in Patients Naive to
Immunomodulators and
BiologicTherapy.
[
Summary
]
| FDA: New Treatments and
Technology |
| Click Title for complete article or
click Summary for overview of each
article.
Lilly
resubmits Cymbalta supplemental New Drug
Application for chronic pain to
FDA
From M2
Europharma - Jun 04,
2009
3 June 2009 -
US pharmaceutical products maker Eli Lilly and
Company said today it has resubmitted its
supplemental New Drug Application for Cymbalta for
the management of chronic pain to the US Food and
Drug Administration. Based on preclinical studies,
Cymbalta is a potent reuptake inhibitor of
serotonin and norepinephrine.
[ Summary
]
EyeGate
Pharma Announces That EGP-437 Improved Signs and
Symptoms of Dry Eye Syndrome in a Phase II
Study
From
Market Wire - Jun 03,
2009
06/03/09 --
Based on the top-level analysis of a Phase II
study, EyeGate Pharma announces that EGP-437, a
corticosteroid solution administered by a
non-invasive ocular drug delivery system, improved
signs and symptoms in patients with dry eye
syndrome.
[ Summary
]
Almotriptan
(Axert/Almogran) Approved by the FDA for the
Treatment of Migraine in
Adolescents
From PharmaLive News Archive -
Jun 02,
2009
BARCELONA, 3rd
June 2009-Almirall announces that the USA
regulatory authorities (FDA), have approved a new
indication for the use of almotriptan
(Axert/Almogran) for the acute treatment of
migraine headache in adolescent patients (age 12
to 17 years).
[ Summary
]
FDA
Forms Transparency Task Force
From PharmaLive News Archive -
Jun 02,
2009
ROCKVILLE,
Md., June 3, 2009--The U.S. Food and Drug
Administration (FDA) today announced the formation
of a task force to develop recommendations for
enhancing the transparency of the agency?s
operations and decision-making
process.
[ Summary
]
Advanced
Life Sciences Announces Outcome of FDA's
Anti-Infective Drugs Advisory Committee Review of
Restanza(TM) (cethromycin)
From PR Newswire US -
Jun 02,
2009
Advanced Life
Sciences Holdings, Inc. announced today that the
FDA's Anti-Infective Drugs Advisory Committee
voted in the majority that Restanza demonstrated
safety for the outpatient treatment of adults with
mild-to-moderate community acquired pneumonia. "We
believe in Restanza's potential and remain
committed to its development.
[ Summary
]
NeurogesX
Receives FDA Orphan Drug Designation for Qutenza
for Treatment of Postherpetic
Neuralgia
From PharmaLive News Archive -
Jun 01,
2009
SAN MATEO,
Calif., June 02, 2009 /PRNewswire-FirstCall/ --
NeurogesX, Inc. , a biopharmaceutical company
focused on developing and commercializing novel
pain management therapies, announced today that
the Office of Orphan Product Development (OOPD) of
the U.S. Food and Drug Administration (FDA) has
granted orphan drug designation for Qutenza(TM)
(formerly NGX-4010), a high concentration
capsaicin dermal patch for the management of
neuropathic pain in patients with postherpetic
neuralgia (PHN).
[
Summary
]
Mylan
wins tentative FDA approval for generic
Singulair
From Datamonitor - Jun 01, 2009
Mylan, a generic pharmaceutical
company, has received tentative approval from the
FDA for its abbreviated new drug application for
montelukast sodium tablets, 10mg. Montelukast
sodium tablets are the generic version of Merck
and Co's Singulair.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
Pa.
governor wants to expand seniors' drug
program
From
Associated Press - Jun
03, 2009
HARRISBURG, Pa._Gov. Ed Rendell
said Tuesday that he hopes to help thousands more
seniors through the recession by making them
eligible to join Pennsylvania's low-cost
prescription drug program. Expanding the state
program known as PACENET requires approval from
the Legislature, and Rendell said he plans to pay
the cost of the expansion by demanding bigger
discounts from pharmaceutical
companies.
[ Summary
]
Time
to Heal: Hospital to Home program to help reduce
the high rate of readmissions [Winston-Salem
Journal, N.C.]
From Winston-Salem Journal (NC)
- Jun 03,
2009
Jun.
3--Recovering from knee-replacement surgery was a
long, aching experience for Lena Kleitches. Two
years ago, she had the replacement surgery, which
was supposed to be followed by a four- to six-week
recuperation and rehabilitation. A problem with
rehabilitation equipment resulted in a painful
wait for immediate help.
[ Summary
]
HealthCare
Maintains Steam While Economy Searches for Bottom:
American HealthCare Capital, a HealthCare Mergers
& Acquisitions Advisory Firm, Releases Second
Quarter (2009) HealthCare Industry
Outlook
From
Market Wire - Jun 02,
2009
06/02/09 --
Economic fundamentals of an aging population
continue to drive growth and consolidation in the
healthcare services industry. The healthcare
services industry remains fairly isolated from
meltdowns in the larger economy, making it
attractive to lenders who want to make credit
available to qualified borrowers that can
withstand stricter underwriting
standards.
[ Summary
]
BCBSNC
Customers Save Millions and Stay on Medications
with Free Generics Program
From PR Web - Jun 02, 2009
BCBSNC customers saved at least $15
million in out-of-pocket costs since January; 2.4
million generic prescriptions filled with no
copay; Customers have until June 30,2009 to save
with the generic copay waiver program. Blue Cross
and Blue Shield of North Carolina is helping
customers save money and stay on their medications
with the generic copay waiver
program.
[ Summary
]
Click Title for complete article or
click Summary for overview of each
article.
New
Clinical Study Shows Over Half of Eligible OGIB
Patients May Benefit From Small Bowel Capsule
Endoscopy as Recommended by GI Society
Guidelines
From Market Wire - Jun 03, 2009
06/03/09 -- Given Imaging Ltd.
today announced a new study that shows over half
of the eligible patients with occult or obscure
gastrointestinal bleeding may benefit from the
additional diagnostic information provided by
small bowel capsule endoscopy in accordance with
existing gastrointestinal society guidelines,
which call for the patient-friendly, non-invasive
procedure following a negative ...
[ Summary
]
Study
points to effective melanoma
drugs
From
UPI Science News - Jun
03, 2009
An
early-stage clinical trial of a new cancer drug
could lead to the creation of effective melanoma
drugs, researchers at a meeting in Orlando,
Fla.,said. The Wall Street Journal said Wednesday
the study presented at the American Society of
Clinical Oncology's annual meeting showed a drug
called PLX4032 was effectively used to shrink
tumors in nine of 16 study
patients.
[ Summary
]
Five
Cord Blood Transplant Centers in Catalonia and
Valencia Join a Study to Test a New Technique to
Treat Leukemia and Lymphoma
From PR Newswire Europe & UK
Disclose - Jun 03,
2009
The Gamida
Cell-Teva Joint Venture announced today that five
prestigious cord blood transplantations centers in
Spain, three in Barcelona and two in Valencia,
have joined the Excel study.
[ Summary
]
Gene
Network Sciences Announces Cancer Collaboration
with University of Connecticut Health Center's
Neag Comprehensive Cancer
Center
From
PR Newswire US - Jun
03, 2009
Gene
Network Sciences, Inc. today announced that it has
entered into a research collaboration with The
University of Connecticut Health Center's Carole
and Ray Neag Comprehensive Cancer Center in which
the parties will incorporate genetic, genomic and
clinical data together into computer models of
different cancers to be used to identify the best
treatments for individual patients and to
develo...
[ Summary
]
Bayer,
Onyx launch Phase III trial of Nexavar drug in
non-small cell lung cancer
From M2 Europharma -
Jun 03,
2009
2 June 2009 -
Bayer HealthCare AG, part of German chemical and
pharmaceutical group Bayer AG, and US Onyx
Pharmaceuticals started a Phase III trial of
Nexavar drug for the treatment of non-small cell
lung cancer. The trial will evaluate Nexavar
tablets in patients with non-squamous non-small
cell lung cancer who have failed two or three
previous treatments, Bayer announced on
Monday.
[ Summary
]
Merck's
Erbitux wins NICE recommendation for use in
colorectal cancer patients
From Datamonitor - Jun 03, 2009
Merck Serono, a subsidiary of
German drugmaker Merck KGaA, has reported that the
UK's National Institute for Health and Clinical
Excellence or NICE has published a final appraisal
determination recommending the use of the drug
Erbitux in combination with chemotherapy as a
first-line treatment for patients with metastatic
colorectal cancer who have met specific additional
criteria presenting the...
[ Summary
]
NAMCP's Medical
Directors Resource Centers
The
purpose of NAMCP's Medical Directors Resource
Centers is to provide Medical Directors with
access to disease specific information and
resources and to improve patient
outcomes.
Accessing NAMCP's Medical
Directors Resource Centers will allow you
to:
Use screening tools to diagnose
Access treatment and best practice guidelines
Improve patient adherence and compliance
Improve patient outcomes
Better manage patients
Review cost of treatment versus overall
economic burden
Provide resources for your network physicians
Provide resources for patients
CLICK
HERE to access the Obesity Resource
Center
CLICK
HERE to access the Sleep Resource
Center
Exclusive
Medical Director's Website
Click
here to sign up for free access to
the exclusive Medical Director's Website. Features
include a discussion forum, career information,
and consolidated clinical links to important
managed care websites. You must be a Medical
Director to gain access to the website. Keep
current on all of the issues surrounding Medical
Directors in today's market. Access is free
for all Medical Directors. Please contact Jeremy
Williams at jwilliams@namcp.org
for more information! For those of you who are
not Medical Directors, please forward the link or
eNews to any Medical Directors in your company
that may be interested in the website.
CLICK THE FOLLOWING TITLES
TO PARTICIPATE IN THE ONLINE
CME/CEU
MS:
The New Treatment Paradigm: A Pathway to Success
for Improved Patient Outcomes
-
Supported by Bayer Healthcare, Inc.
How
to Improve Outcomes in a Patient Population of
Asthmatics
- Supported by
AstraZeneca
Stroke:
Primary and Secondary Prevention
-
Supported by Bristol-Myers Squibb
Economic
Value of the Prevention and Treatment of Diabetic
Ulcers
- Supported by KCI
Management
of the Liver Transplant Patient
-
Supported by Astellas
The
Relationship & Impact of Osteoporosis &
Breast Cancer in Post Menopausal
Women
- Supported by Eli Lilly
Implementation
of Comprehensive RSV Management Plan to Improve
Patient, Provider and Plan
Outcomes
- Supported by MedImmune,
Inc.
Diagnosis
and Management of HBV in Managed
Care
- Supported by Gilead
Sciences
Diabetes:
When Behavior Modification is Not
Enough
- Supported by
GlaxoSmithKline
Pain
Management
- Supported by Alpharma
Pharmaceuticals
Obesity
Management
- Supported by Allergan,
Inc.
Health
Economic Implications of Wound Care and Limb
Preservation
- Supported by KCI,
Inc.
| Journal of Managed Care
Medicine |
Your Logo
Here |
Journal of Managed Care
Medicine Vol 12, Issue 2 Table of
Contents
 Below
you will find the table of contents for the
current issue of JMCM. You can click
here to visit our main journal page, or
click on each individual article below to visit
their article page and then download the
PDF!
Click
the titles below to visit the indvidual article
download page.
How
to Improve Outcomes in a Patient Population of
Asthmatics
Gary Owens,
MD
Stroke
Prevention in an At Risk
Population
John Varras,
MD
Economic
Value of the Prevention & Treatment of
Diabetic Ulcers
Lawrence
Lavery, DPM, MPH
Prevention
and Treatment of DVT and
PE
Darrell Harrington,
MD
Management
of the Liver Transplant
Patient
Steven Flamm,
MD
How
to Manage & Treat a Psoriatic Arthritis
Patient Population to Improve Patient
Outcomes
Phillip Mease,
MD
Complete
12.2
Issue
| Press
Release |
Your Logo
Here |
America Needs Business
Numbers
In December, the U.S.
Census Bureau mailed Economic Census forms to more
than 4 million businesses - to all large and
medium businesses and many small businesses. If
you received a form, the law (Title 13, U.S. Code)
requires that you complete and return it. The due
date is February 12, less than a month
away.
Economic indicators we use all the
time -- like Gross Domestic Product, monthly
retail sales, and the producer price index -- all
depend on the Economic Census for continued
accuracy. The data are also used by businesses
large and small, and by this association. Ben
Bernanke says this census is "indispensable to
understanding America's economy."
If you
need more information or help completing the form,
see the Census Bureau's business help site at www.census.gov/econhelp
or call 1-800-233-6136.
America needs your
numbers.
| Job
Postings |
Your Logo
Here |
Visit NAMCP's Career
Center!
To find a job or fill a position, visit
http://careers.namcp.org.
You can also click on the links following each
individual job below to be taken to their new page
on our career center.
Job
seekers and employers have discovered the
advantages of searching online for the best jobs
and for qualified candidates to fill them. But,
the mass-market approach of the mega job boards
may not be your best avenue.
NAMCP's Career
Center gives employers and job seeking managed
care professionals a better way to find one
another and make that perfect career
fit.
For Job Seekers: Post your
resume; Search job listings; Set up Search Agents;
and have new postings sent to you via
email.
For Employers: Post your
jobs; Target a focused audience of candidates;
Search resumes; Track applications; Promote your
company online.
If you
would like to post a job on Genomics Biotech
eNews, please contact Sloane Reed at
sreed@namcp.org or 804-527-1905 for
rate information.
In
accordance with our mission, to enhance the
ability of our members to succeed in their
careers, we are pleased to offer comprehensive
career consultation and national executive
placement services. As a benefit of membership for
our client organizations, i.e., anyone seeking to
hire experienced staff, we offer exceptional
executive search services and at a discounted
rate. We have access to the highest caliber of
managed care talent and have a distinguished track
record in placing physician and nurse executives
as well as executive operations personnel (CEO,
COO, CFO, Director of Managed Care, Network
Development, etc.)
If you have an available
position or have an interest in our placement
service, please contact David Mara at
(804)527-1905 or e-mail at dmara@namcp.org.
For a more detailed job description for any of
the jobs listed below, please contact Dave Mara at
804.527.1905 or email him at dmara@namcp.org
You
can also CLICK HERE to visit our Job
Placement and Career Counseling page to view the
full descriptions for all of these jobs and
more!
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Gastroenterology
therapeutic area but later may involve in other
therapeutic areas as derived from the company's
pipeline and/or in licensed development products.
While the individual is expected to manage the
conduct of clinical trials in the US, there is a
strong component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
Medical Director
New
Jersey
Job Summary
The
Medical Director reports to the Vice President of
Infertility and Orthopedics. The incumbent is
responsible for developing and implementing
product development strategies initially in the
OBGYN therapeutic areas but later may involve in
other therapeutic area; as derived from the
company pipeline and/or in licensed development
products. While the individual is expected to
manage the conduct of clinical trials in the US
there is a strong component involving
participation in global project development teams
managed from the company's International Center in
Copenhagen. The Medical Director will be expected
to undertake all the duties normally associated
with the execution of clinical trials and to
establish clinical advisory boards in the areas of
product development.
For more information,
please call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Medical Director, Clinical Research, North
America
New Jersey
Job
Summary
The Medical Director-Clinical
Research, North America reports to the Executive
Medical Director. The incumbent is responsible for
developing and implementing product development
strategies initially in the Urology therapeutic
area but later may involve in other therapeutic
area as derived from the company's pipeline and/or
in licensed development products. While the
individual is expected to manage the conduct of
clinical trials in the US there is a strong
component involving participation in global
project development teams. The Medical Director
will be expected to undertake all the duties
normally associated with the execution of clinical
trials and to establish clinical advisory boards
in the areas of product development.
For
more information, please call David Mara at
804.527.1905. To review additional positions go to
www.nexushc.com
Chief Medical Officer
San Francisco,
CA
Job Summary
The Chief
Medical Officer (CMO) for the Healthcare Services
organization will be integral in the realization
of the health plan's mission, by providing
leadership and direction for health management and
clinical quality improvement strategies, providing
greater value to its members through pharmacy and
medical management, and optimally functioning
management systems.
For more information,
please call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Associate Medical Director
Nashville, TN
Job Summary
Working with the
Chief Medical Director, oversees medical care for
the health plan's products and services and
oversees the health care needs of the membership.
Serves as a medical manager and policy advisor to
the company and health plan Chief Medical
Director. Is accountable for and provides
professional leadership and direction to the
utilization/cost management and clinical quality
management functions. Works collaboratively with
other plan functions that interface with medical
management such as provider relations, member
services, benefits and claims management, etc.
Assists (as determined by the plan Chief Medical
Director) in short and long range program
planning, total quality management (quality
improvement) and external
relationships.
For more information, please
call David Mara at 804.527.1905. To review
additional positions go to www.nexushc.com
Chief Medical Officer
Nashville, TN
Overview
Oversees all
medical care for the health plan's products and
services. Oversees the health care needs of the
membership. Serves as the principal medical
manager and policy advisor to the company and
health plan CEO or COO. Is accountable for and
provides professional leadership and direction to
the utilization/cost management and clinical
quality management functions. Works
collaboratively with other plan functions that
interface with medical management such as provider
relations, member services, benefits and claims
management, etc.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
MEDICARE HMO EXPANDING - NEW MARKET
OPPORTUNITY
Medical Director
Mobile,
AL
Job Summary
This position
is responsible for the administration of all
medical services for the corporation. It is
responsible for the coordination of medical
policy, peer review, quality management,
legal/medical issues, and the effectiveness of the
Medical Management Program.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
Medical Director
Virtual
Job
Summary
A leading healthcare technology and
service company that provides solutions for
healthcare organizations, has a unique experience
base, extensive healthcare information and
advantaged technology applications which create
value through reduced medical costs, reduced
administrative costs and improved care
coordination is seeking a Medical Director to
support a growing client base and maintain their
competitive advantage in the depth of clinical
logic.
The Medical Director is instrumental
within the company in directing the Logic
Committee (Medical Policy Committee) which is
composed of medical directors, coding analysts,
provider relations, contracting people, etc. At
the Logic Committee, the company goes through
their Global Medical Policy document as it relates
to claims coding and then subsequently reviews
individual edits that have potential value for the
client.
Please direct all inquires to Dave
Mara at 804-527-1905.
Manager, Provider Relations and
Contracting
Austin, TX; Ft. Lauderdale; Orlando
and Tampa, FL
Summary
This
behaviorial health company is a multi-line managed
care organization that provides Medicaid-related
programs to organizations and individuals through
government subsidized programs. We have an
excellent opportunity for a Manager of Provider
Relations and Contracting. This position will
implement development activities for the
recruitment, contracting and retention of
providers. Negotiate contracts and develop
strategies and methodologies for specific network
development initiatives.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
Director, Pharmacy Services
(Corporate)
Virtual
For a more
detailed description of this job, please contact
Dave Mara at 804.527.1905 or email him at dmara@namcp.org
Vice President of Health
Services
Birmingham, AL; Miami, FL; Chicago,
IL; New Orleans, LA
Position
Summary
Responsible for the development,
implementation, and management of programs for a
national Medicare HMO
For a more
detailed description of this job, please contact
Dave Mara at 804.527.1905 or email him at dmara@namcp.org
Senior Medical Director
Houston,
TX
This position is responsible for the
administration of all medical services for the
corporation.
Please
click here to visit the webpage for this
job opportunity, including a detailed job
description!
| | |
| Genomics Biotech Institute eNews
for June 4, 2009 |
Produced by NAMCP & Genomics Biotech
Institute
4435 Waterfront Drive, Suite
101
Glen Allen, VA 23060
Telephone:
804-527-1905
Fax: 804-747-5316 |
Click "Opt-out of this
newsletter" at the top of the newsletter or
contact Jeremy Williams at jwilliams@namcp.org
or 804-527-1905 to be taken off the
list | | | | |
|
| JOURNAL OF MANAGED CARE MEDICINE
(JMCM) |
|
Vol. 12, No. 2 has been
released! Scroll below to the Journal Section
below for downloadable
articles! | | |
| EMPLOYMENT
OPPORTUNITIES |
|
Call Dave Mara at (804) 527-1905 for
information on any of the following job
openings.
Medical Director, Clinical Research, North
America, New Jersey
Medical Director, New Jersey
Chief Medical Officer, San Francisco, CA
Medical Director, Mobile, AL
Medical Director, Virtual
Chief Medical Officer, Nashville, TN
Manager, Provider Relations and Contracting,
Austin, TX; Ft. Lauderdale, Orlando and Tampa,
FL
VP of Health Services, Birmingham, AL, Miami,
FL and New Orleans, LA
VP, Health Care Management Services, Multiple
Locations
Senior Medical Director, Houston,
TX
For more information or for more
detailed job descriptions, please contact Dave
Mara at 804.527.1905 or email your resume to dmara@namcp.org
| | |
|
